Danish Economy Bounces Back to Growth Led by Drugmakers

Denmark’s economy rebounded in the second quarter, as the strength of the broader pharmaceuticals industry helped to outweigh the impact of weaker sales of Novo Nordisk A/S’s blockbuster weight-loss drugs.

Gross domestic product, adjusted for seasonal swings, rose 1.3% from the previous three months, when it contracted 1.3%, Statistics Denmark said on Wednesday in a preliminary reading. The growth in the second quarter was driven by a bounce-back among drugmakers, with increased oil extraction also contributing, the statistics agency said.